Patrick D Yeramian Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity
Patrick D Yeramian is Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 205,605 shares of AMLX, which is worth approximately $1.02 Million. The most recent transaction as insider was on Jan 09, 2024, when has been sold 2,812 shares (Common Stock) at a price of $16.33 per share, resulting in proceeds of $45,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
206K
0%
3M change
1.35%
12M change
Total Value Held
$1.02 Million
Patrick D Yeramian Transaction History
PDY
Patrick D Yeramian
Chief Medical Officer
Cambridge, MA